RecruitingNCT05788432

Sequent Extended Study

Sequent Please Neo Extended Post-Market Clinical Follow-up Study

Sponsor

Fundación EPIC

Enrollment

2,028 participants

Start Date

Mar 28, 2023

Study Type

OBSERVATIONAL

Conditions

Coronary Artery Disease Ischemic Heart Disease

Summary

Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Sequent Please Neo to meet EU Medical Device regulation (MDR) requirements in all the consecutive patients treated with Sequent Please Neo.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Sequent Please Neo for people with coronary artery disease and ischemic heart disease. The study is currently recruiting participants at 27 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESequent Please Neo

Patients in whom treatment with (Sequent Please Neo) has been attempted

Locations(27)

Hospital Universitario de Araba

Alava, Spain

Hospital General Universitario de Alicante Dr.Balmis

Alicante, Spain

Hospital Universitario de Badajoz

Badajoz, Spain

Hospital Universitari Germans Trias I Pujol

Badalona, Spain

Hospital Universitario de Cruces

Barakaldo, Spain

Hospital de La Santa Creu Y Sant Pau

Barcelona, Spain

Hospital Clinic de Barcelona

Barcelona, Spain

Hospital Universitario Puerta Del Mar

Cadiz, Spain

Hospital General Universitari de Castelló

Castelló, Spain

Hospital Universitario San Pedro de Alcantara

Cáceres, Spain

Hospital Universitario de Ciudad Real

Ciudad Real, Spain

Hospital General Universitario de Elche

Elche, Spain

Hospital Universitario de Cabueñes

Gijón, Spain

Hospital Universitari Dr. Josep Trueta

Girona, Spain

Hospital Universitario Juan Ramon Jimenez

Huelva, Spain

Hospital Universitario de Jaen

Jaén, Spain

Hospital Universitario de Leon

León, Spain

Hospital Universitario Lucus Agusti

Lugo, Spain

Hospital Universitario de La Princesa

Madrid, Spain

Hospital Universitario 12 de Octubre

Madrid, Spain

Hospital Regional Universitario de Malaga

Málaga, Spain

Hospital Universitario Virgen de La Victoria

Málaga, Spain

Hospital de Mérida

Mérida, Spain

Hospital Universitario Puerto Real

Puerto Real, Spain

Hospital Clinico Universitario de Salamanca

Salamanca, Spain

Hospital Universitario Virgen Del Rocio

Seville, Spain

Hospital General Universitario de Toledo

Toledo, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05788432

Related Trials

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

NCT072582901 location

Product Surveillance Registry

NCT01524276395 locations

DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.

NCT0665783313 locations

Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation

NCT0686315512 locations

Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions

NCT0719069016 locations